References
1. Sullivan M, Bouffet E,
Rodriguez-Galindo C, Luna-Fineman S, Khan MS, Kearns P, et al. The
COVID-19 pandemic: A rapid global response for children with cancer from
SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global.
Pediatr Blood Cancer. 2020;67: e28409.
2. Montoya J, Ugaz C, Alarcon
S, Maradiegue E, García J, Díaz R, et al. COVID‐19 in pediatric cancer
patients in a resource‐limited setting: National data from Peru.
Pediatric Blood & Cancer. 2021.
doi:10.1002/pbc.28610
3. López-Aguilar E,
Cárdenas-Navarrete R, Simental-Toba A, Pacheco-Rosas D, Thomé-Ortiz P,
Soto-Pérez G, et al. Children with cancer during COVID-19 pandemic:
Early experience in Mexico. Pediatric blood & cancer. 2021. p. e28660.
4. Graetz D, Agulnik A,
Ranadive R, Vedaraju Y, Chen Y, Chantada G, et al. Global effect of the
COVID-19 pandemic on paediatric cancer care: a cross-sectional study.
Lancet Child Adolesc Health. 2021;5: 332–340.
5. Millen GC, Arnold R,
Cazier J-B, Curley H, Feltbower RG, Gamble A, et al. Severity of
COVID-19 in children with cancer: Report from the United Kingdom
Paediatric Coronavirus Cancer Monitoring Project. Br J Cancer. 2021;124:
754–759.
6. Connelly JA, Chong H,
Esbenshade AJ, Frame D, Failing C, Secord E, et al. Impact of COVID-19
on Pediatric Immunocompromised Patients. Pediatr Clin North Am. 2021;68:
1029–1054.
7. Madhusoodhan PP, Pallavi
Madhusoodhan P, Pierro J, Musante J, Kothari P, Gampel B, et al.
Characterization of COVID‐19 disease in pediatric oncology patients: The
New York‐New Jersey regional experience. Pediatric Blood & Cancer.
2021. doi:10.1002/pbc.28843
8. Kebudi R, Kurucu N, Tuğcu
D, Hacısalihoğlu Ş, Fışgın T, Ocak S, et al. COVID‐19 infection in
children with cancer and stem cell transplant recipients in Turkey: A
nationwide study. Pediatric Blood & Cancer. 2021.
doi:10.1002/pbc.28915
9. Mukkada S, Bhakta N,
Chantada GL, Chen Y, Vedaraju Y, Faughnan L, et al. Global
characteristics and outcomes of SARS-CoV-2 infection in children and
adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021;22:
1416–1426.
10. de Rojas T,
Pérez-Martínez A, Cela E, Baragaño M, Galán V, Mata C, et al. COVID-19
infection in children and adolescents with cancer in Madrid. Pediatr
Blood Cancer. 2020;67: e28397.
11. Nicastro E, Verdoni L,
Bettini LR, Zuin G, Balduzzi A, Montini G, et al. COVID-19 in
Immunosuppressed Children. Frontiers in Pediatrics. 2021.
doi:10.3389/fped.2021.629240
12. Zachariah P, Johnson CL,
Halabi KC, Ahn D, Sen AI, Fischer A, et al. Epidemiology, Clinical
Features, and Disease Severity in Patients With Coronavirus Disease 2019
(COVID-19) in a Children’s Hospital in New York City, New York. JAMA
Pediatr. 2020;174: e202430.
13. Flores V, Miranda R,
Merino L, González C, Serrano C, Solano M, et al. SARS-CoV-2 infection
in children with febrile neutropenia. Ann Hematol. 2020;99: 1941–1942.
14. Corso MCM, Soares VJ,
Amorim AMP, Cipolotti R, Magalhães IMQ, Lins MM, et al. SARS-CoV-2 in
children with cancer in Brazil: Results of a multicenter national
registry. Pediatr Blood Cancer. 2021;68: e29223.
15. Dorantes-Acosta E,
Ávila-Montiel D, Klünder-Klünder M, Juárez-Villegas L, Márquez-González
H. Survival and Complications in Pediatric Patients With Cancer and
COVID-19: A Meta-Analysis. Front Oncol. 2020;10: 608282.
16. Vijenthira A, Gong IY,
Fox TA, Booth S, Cook G, Fattizzo B, et al. Outcomes of patients with
hematologic malignancies and COVID-19: a systematic review and
meta-analysis of 3377 patients. Blood. 2020;136: 2881–2892.
17. Bisogno G, Provenzi M,
Zama D, Tondo A, Meazza C, Colombini A, et al. Clinical Characteristics
and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
in Italian Pediatric Oncology Patients: A Study From the Infectious
Diseases Working Group of the Associazione Italiana di Oncologia e
Ematologia Pediatrica. Journal of the Pediatric Infectious Diseases
Society. 2020. pp. 530–534.
doi:10.1093/jpids/piaa088
18. Rouger-Gaudichon J,
Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, et al. COVID19
and acute lymphoblastic leukemias of children and adolescents: Updated
recommendations (Version 2) of the Leukemia Committee of the French
Society for the fight against Cancers and leukemias in children and
adolescents (SFCE). Bulletin du Cancer. 2021. pp. 490–500.
doi:10.1016/j.bulcan.2021.02.004
19. Baruchel A, Bertrand Y,
Boissel N, Brethon B, Ducassou S, Gandemer V, et al. COVID-19 and acute
lymphoblastic leukemias of children and adolescents: First
recommendations of the Leukemia committee of the French Society for the
fight against Cancers and Leukemias in children and adolescents (SFCE).
Bull Cancer. 2020;107: 629–632.
20. Fonseca EV, Pardo CA,
Linares A, López JF, Camacho G, Aponte NH, et al. Clinical
Characteristics and Outcomes of a Cohort of Pediatric Oncohematologic
Patients With COVID-19 Infection in the City of Bogotá, Colombia.
Pediatr Infect Dis J. 2021;40: 499–502.
21. Ferrari A, Zecca M,
Rizzari C, Porta F, Provenzi M, Marinoni M, et al. Children with cancer
in the time of COVID-19: An 8-week report from the six pediatric
onco-hematology centers in Lombardia, Italy. Pediatric blood & cancer.
2020. p. e28410.
22. Instituto Nacional de
Estadística y Censos (Argentina). Estimaciones y proyecciones de
población 2010-2040: total del país. 2014.
23. Dong Y, Mo X, Hu Y, Qi X,
Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in
China. Pediatrics. 2020. p. e20200702.
doi:10.1542/peds.2020-0702
24. Qiu H, Wu J, Hong L, Luo
Y, Song Q, Chen D. Clinical and epidemiological features of 36 children
with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an
observational cohort study. Lancet Infect Dis. 2020;20: 689–696.
25. Fang F, Chen Y, Zhao D,
Liu T, Huang Y, Qiu L, et al. Recommendations for the Diagnosis,
Prevention, and Control of Coronavirus Disease-19 in Children-The
Chinese Perspectives. Front Pediatr. 2020;8: 553394.
26. Boletín Integrado de
Vigilancia. Edición Semanal. BIV 591 | SE 9/2022. Ministerio de
Salud de la Nación; SE 9 Año 2022.
27. Hrusak O, Kalina T, Wolf
J, Balduzzi A, Provenzi M, Rizzari C, et al. Flash survey on severe
acute respiratory syndrome coronavirus-2 infections in paediatric
patients on anticancer treatment. Eur J Cancer. 2020;132: 11–16.
28. Meena JP, Kumar Gupta A,
Tanwar P, Ram Jat K, Mohan Pandey R, Seth R. Clinical presentations and
outcomes of children with cancer and COVID-19: A systematic review.
Pediatr Blood Cancer. 2021;68: e29005.
29. A multicenter study of
confirmed COVID-19 cases: preliminary data on 2690 pediatric patients in
Argentina during the first year of the pandemic. Archivos Argentinos de
Pediatría. 2022.
doi:10.5546/aap.2022.eng.80
30. Cribado de SARS-CoV-2 en
pacientes pediátricos con cáncer previo a hospitalización para infusión
de quimioterapia. Archivos Argentinos de Pediatría. 2022.
doi:10.5546/aap.2022.118
31. Boulad F, Kamboj M,
Bouvier N, Mauguen A, Kung AL. COVID-19 in Children With Cancer in New
York City. JAMA Oncol. 2020;6: 1459–1460.
32. Moreira DC, Millen GC,
Sands S, Kearns PR, Hawkins DS. The Care of Children With Cancer During
the COVID-19 Pandemic. Am Soc Clin Oncol Educ Book. 2021;41: 1–10.
33. Liang W, Guan W, Chen R,
Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a
nationwide analysis in China. The Lancet Oncology. 2020. pp. 335–337.
doi:10.1016/s1470-2045(20)30096-6